Goldenberg F, Richalet J P, Jouhandin M, Gisquet A, Keromes A, Larmignat P
Laboratoire d'EEG, Hôpital Henri Mondor, Créteil.
Presse Med. 1988 Mar 19;17(10):471-4.
Sleep and respiration studies were carried out in 12 subjects (9 males, 3 females) at an altitude of 4,800 metres, during effect of a French expedition in the Himalayas. The effect of loprazolam, a hypnotic benzodiazepine, was investigated in a double-blind, 2 parallel group, 1 mg loprazolam versus placebo trial. Sleep was evaluated by means of electroencephalographic recordings and questionnaires. The effects of altitude in each subject were intercurrent wakefulness increase, slow wave sleep and paradoxical sleep decrease and nocturnal periodic breathing. The mean duration of sleep apnea episodes was 12 seconds with a maximum of 24 seconds. These episodes occurred during stages 1 or 2 of sleep and during paradoxical sleep. Female subjects exhibited less periodic breathing than males. Acclimatization to high altitude increased total sleep time, stage 3 duration and percentage of paradoxical sleep. Loprazolam tended to decrease stage 2 latency and did not worsen slow wave sleep depression or episodes of apnea. Normal amounts of slow wave sleep and intrasleep wakefulness appeared in the loprazolam group after acclimatization.
在一次法国喜马拉雅山探险期间,对12名受试者(9名男性,3名女性)在海拔4800米处进行了睡眠与呼吸研究。在一项双盲、两组平行、1毫克氯普唑仑与安慰剂对照试验中,研究了催眠性苯二氮䓬类药物氯普唑仑的效果。通过脑电图记录和问卷调查对睡眠进行评估。海拔对每个受试者的影响包括清醒时间增加、慢波睡眠和异相睡眠减少以及夜间周期性呼吸。睡眠呼吸暂停发作的平均持续时间为12秒,最长为24秒。这些发作发生在睡眠的第1或第2阶段以及异相睡眠期间。女性受试者的周期性呼吸比男性少。对高海拔的适应增加了总睡眠时间、第3阶段持续时间和异相睡眠百分比。氯普唑仑倾向于减少第2阶段潜伏期,且未加重慢波睡眠抑制或呼吸暂停发作。适应后,氯普唑仑组出现了正常量的慢波睡眠和睡眠中清醒。